Key result
Cardiac troponins may be persistently elevated in patients with chronic kidney disease even without overt symptoms, serving as a marker of global cardiovascular risk.
Cardiac troponins may be persistently elevated in patients with chronic kidney disease without overt cardiovascular symptoms, acting as a marker of global cardiovascular risk.
Requires cautious troponin interpretation in CKD to avoid misdiagnosing ACS; leaves open CKD-specific thresholds for validation.
Cardiac Troponins in CKD: Upscaling Our UnderstandingCardiac troponins may be persistently or "chronically" elevated in patients with CKD, even in those free of overt CV symptoms [2] .
No takes yet. Share an insight, caveat, or question.
Vaduganathan et al. (2017) studied this question. Cardiac troponins may be persistently elevated in patients with chronic kidney disease even without overt symptoms, serving as a marker of global cardiovascular risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: